MEDIA RELEASE
ElderCare Appoints New Director to the Board
Auckland – March 14, 2002 – Listed healthcare provider, ElderCare New Zealand (NZSE: ELD) today announced that it has
appointed Dr Clint Teague, managing partner of the recently acquired Medical Laboratory Wellington and Nelson Diagnostic
Laboratories, to its board of directors.
Said ElderCare’s CEO and director, Alan Clarke, “We are very pleased with the opportunity to have Dr Teague join the
board. He brings a wealth of experience in the pathology industry to the company, and as ElderCare’s growth unfolds we
will draw on this medical experience.”
The appointment follows a successful capital raising last year, and the acquisition of the Wellington and Nelson
pathology businesses in January 2002.
ENDS
Company Background
ElderCare New Zealand Limited (NZSE: ELD) is a medical and healthcare service provider. The company owns a substantial
portfolio of nursing homes, assisted living, assessment and rehabilitation facilities throughout New Zealand, and two
pathology businesses. These offer an array of specialised services to cater for the healthcare needs of a broad range of
New Zealanders. The company has embarked on a programme that will see it expand its operations into other fee income
generating businesses in the wider healthcare sector.